Abstract
Zetasizer is an advanced device that measures various properties of particles or molecules suspended in a liquid medium. It is extensively used for evaluating the size of nanoparticles, colloids, and biomolecular particles, and for determining particle charge. There are several analytical techniques by which the size, zeta potential, and molecular weight can be determined, like Dynamic Light Scattering (DLS) that measures the size of particles in dispersed systems, which can range from sub-nanometers to several micrometers in diameter. Electrophoretic Light Scattering (ELS) analyzes the mobility and charge of particles, also known as the zeta potential. Static Light Scattering (SLS) determines the molecular weight of particles in a solution. The Zetasizer is part of the Zetasizer Advance range of benchtop systems available for laboratory use. The Zetasizer Ultra model offers unique measurement capabilities, such as Multi-angle Dynamic Light Scattering (MADLS) and particle concentration. These features offer a deeper understanding of samples, making the Zetasizer a vital instrument in numerous scientific and industrial applications. In this review, we have discussed Zetasizer’s principles for the determination of particle size, zeta potential, and molecular weight, along with its qualification and applications in different formulations.
Graphical Abstract
[http://dx.doi.org/10.3390/colloids7010015]
[http://dx.doi.org/10.1007/s12551-016-0218-6] [PMID: 28510011]
[http://dx.doi.org/10.1007/s00723-023-01529-8]
[http://dx.doi.org/10.1016/j.carbpol.2013.01.025] [PMID: 23544520]
[http://dx.doi.org/10.1016/j.colsurfa.2015.08.044]
[http://dx.doi.org/10.1016/j.jddst.2021.102390]
[http://dx.doi.org/10.1016/j.sjbs.2018.01.007] [PMID: 31516350]
[http://dx.doi.org/10.1021/jf4001567] [PMID: 23414105]
[http://dx.doi.org/10.1016/j.microc.2020.104962]
[http://dx.doi.org/10.1016/j.foodchem.2018.06.140] [PMID: 30100436]
[http://dx.doi.org/10.1016/j.jcis.2012.01.007] [PMID: 22305420]
[http://dx.doi.org/10.1016/j.ijpharm.2005.02.032] [PMID: 15885454]
[http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v26.i5.10]
[http://dx.doi.org/10.3109/10837450.2013.795167] [PMID: 23675949]
[http://dx.doi.org/10.1039/C5SM02958A] [PMID: 26924445]
[http://dx.doi.org/10.3390/molecules25071538] [PMID: 32230976]
[http://dx.doi.org/10.3109/10717544.2013.859186] [PMID: 24266589]
[http://dx.doi.org/10.1007/978-1-4939-1417-3_7]
[http://dx.doi.org/10.1016/j.msec.2020.111548] [PMID: 33321612]
[http://dx.doi.org/10.4103/1735-5362.235156] [PMID: 30065762]
[http://dx.doi.org/10.2147/IJN.S2.3.289] [PMID: 18019829]
[http://dx.doi.org/10.1016/j.ijpharm.2014.08.008] [PMID: 25108048]
[http://dx.doi.org/10.1515/ntrev-2022-0109]
[http://dx.doi.org/10.3390/molecules27010289] [PMID: 35011520]
[http://dx.doi.org/10.1007/978-981-33-4497-6_4]
[http://dx.doi.org/10.4103/0110-5558.72415] [PMID: 22247858]
[http://dx.doi.org/10.1055/a-1286-5750] [PMID: 33137836]
[http://dx.doi.org/10.1213/ANE.0b013e3182937b74] [PMID: 23744957]
[http://dx.doi.org/10.1016/j.ejps.2021.106101]
[http://dx.doi.org/10.1016/j.jddst.2021.102998]
[PMID: 24711824]